Ildar Fakhradiyev
Ildar Fakhradiyev is an expert in Surgery at Kazakh National Medical University (Kazakhstan). As of October 2026, ScienceLeadR ranks Ildar Fakhradiyev in the top 1% of experts in Kazakhstan for Epidemiologic Studies. Ildar Fakhradiyev has authored 121 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 2 of them ongoing. SLR score: 508 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Public Health - Biochemistry - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2016 - 2026
Number : 121
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. PMID 42385762 — fasting, mortality, tuberculosis, multidrug-resistant, incidence, global health, pharmaceutical preparations, global burden of disease, hiv, tuberculosis, risk factors, morbidity, cost of illness, smoking, communicable diseases, plasma | Lancet Infect Dis Top journal | 2026 | 2 |
| Vibroacoustic lung therapy and early postoperative oxygenation after cardiac surgery: a multicentre prospective study. PMID 42866655 — lung, drug-related side effects and adverse reactions, therapeutics, prospective studies | Front Med (Lausanne) | 2026 | 0 |
| Global, Regional, and National Burden of Heart Failure, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023. PMID 42814432 — heart diseases, heart failure, heart, cardiovascular diseases, public health, global burden of disease, prevalence, cost of illness, chagas disease | JAMA Cardiol | 2026 | 0 |
| Nationwide Trends in Newborn Anthropometric Indicators in Kazakhstan, 2013-2022: A Population-Level Time-Trend Analysis. PMID 42650407 — growth, parturition, infant, newborn, birth weight, prevalence, records | Children (Basel) | 2026 | 0 |
| Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023. PMID 42525403 — myocardial ischemia, heart diseases, cholesterol, ldl, growth, ischemic stroke, stroke, heart, aging, uncertainty, global burden of disease, cost of illness, therapeutics, demography | JAMA Top journal | 2026 | 6 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 3
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Epigenetics and NCD Prevention in Kazakhstan Personalized Approaches and Biological Age Prediction NCT06953180 — diabetes mellitus, respiration disorders, kidney diseases, intelligence, respiratory tract diseases, respiration, preventive medicine, cardiovascular diseases, kidney, noncommunicable diseases, dna methylation, obesity, precision medicine, artificial intelligence, dna, renal insufficiency, communicable diseases, telomere, renal insufficiency, chronic, diabetes mellitus, type 2 | N/A | Recruiting | 2025 |
| Global Evaluation of Cholecystectomy Knowledge and Outcomes NCT06223061 — bile, gallstones, gallbladder, emergencies, bile ducts, neoplasms, cholecystectomy, gallbladder neoplasms | N/A | Active not recruiting | 2023 |
LeadR Networks
Main global connection map